96 computer-science-programming-languages-"U.S"-"U.S" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug discovery
-
cancer patients. The lab employs cutting-edge technologies (immunopeptidomics, T cell engineering, single-cell transcriptomics, spatial transcriptomics, CRISPR technologies) paired with in vivo animal
-
and Center for RNA Biology, Cancer & Blood Disorders Institute, Johns Hopkins All Children’s Hospital, in St. Petersburg, FL. The Perera laboratory employs a combination of biochemical, genetic, genomic
-
them in relation to literature in biology and psychology, and communicate them orally and in writing in English. Good knowledge of English is therefore required, as well as the ability to assimilate and
-
to provide a more integrated picture of life processes in the context of health and disease. To be a postdoc fellow at the AMBER programme you will get unprecedented medical, biological, and methodological
-
, in particular in working with zebrafish, Experience in public science communication, Good oral and written language skills in Norwegian/Scandinavian. Personal characteristics Working as a Postdoctoral
-
projects that leverage our optical expertise to probe brain function Preferred Qualifications & Expertise: PhD in neuroscience, bioengineering, computational biology, or related field At least one strong
-
University. The ideal candidate will collaborate closely with both clinicians and computational researchers to develop and apply novel methods for understanding the biology of brain disorders and/or
-
integrative therapy approaches. As a successful candidate you will: Devise, plan, document, and advance basic science and translational projects in genetics, epigenetics, and precision oncology
-
programme is focused on 1) understanding the biology of paediatric medulloblastoma with a particular focus on the role of myc as an oncogenic driver, 2) exploiting therapeutic vulnerabilities in combination